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Abstract
The objective was to determine the effects of corticotherapy, in the presence and absence of uterine inflammation, on
proteomics of endometrial fluid from mares susceptible to endometritis. In 11 mares, estrus was induced seven times with 5 mg
PGF2 given at 14-day intervals. The first estrus was a control (no treatment). During the third estrus, mares received
lucocorticoid (GC) treatment (20 mg isoflupredone acetate) every 12 h, for three consecutive days. The fifth estrus was the
nfected treatment (intrauterine infusion of 1  109 colony-forming unit/mL Streptococcus equi subspecies zooepidemicus).
inally, the seventh was a combination of GC  Infected treatment (infusion of bacteria 24 h after the first GC treatment). At 12 h
fter the end of each treatment, uterine samples were collected and submitted to two-dimensional polyacrylamide gel electro-
horesis (2D-PAGE) for protein separation and mass spectrometry. Both GC treatment and uterine lumen infection induced
roteomic alterations in the endometrial fluid of susceptible mares, characterized by an increase, decrease, or both in the relative
ptic density and/or frequency of inflammatory acute phase proteins (APP), with major alterations occurring when corticotherapy
as applied in the presence of an infectious process. Corticotherapy in the presence of infection increased 1-antitrypsin (AAT),
ransthyretin (TT), and actin, but reduced immunoglobulin G, whereas intrauterine infection increased haptoglobin (Hp) and
polipoprotein A-1 (ApoA-1) and decreased transferrin (TF). Infection reduced levels of 1-antitrypsin and transthyretin, whereas
orticotherapy in the presence of infection increased their frequency. We concluded that GC influenced the immune response, not
nly as suppressors, but also as enhancers of local defense mechanisms, through an immunomodulatory action. Short-term
orticotherapy could be beneficial for treatment of uterine infectious processes in the mare.
 2012 Elsevier Inc. Open access under the Elsevier OA license.
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h1. Introduction
Endometritis is one of the major causes of infertility
in the mare [1]. The most common form of endometritis
is that induced by breeding [2], a transient physiolog-
ical event to remove excess sperm, seminal plasma, and
* Corresponding author. Tel.: 55 51 3308-6124; fax: 55 51
3308-6124.rE-mail address: cvetwolf@yahoo.com.br (C.A. Wolf).
093-691X © 2012 Elsevier Inc. Open access under the Elsevier OA license.
oi:10.1016/j.theriogenology.2011.10.042contaminants from the uterus [3]. Mares that fail to
clear the semen-induced inflammation from the uterus
develop a persistent mating-induced endometritis [4]
and are classified as susceptible to endometritis [5].
usceptibility affects 15% of Thoroughbred mares; [6]
arly embryonic death rates are three times higher in
ares with this condition [7].
The concept of a resistant versus susceptible mare
as been known for decades. Changes in the immune
esponse that render a mare susceptible have not been
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1352 C.A. Wolf et al. / Theriogenology 77 (2012) 1351–1359elucidated, but it is generally attributed to a defective or
poorly orchestrated immune system. Furthermore, little
is known regarding the local immunologic changes
associated with endometritis [8]. Resistant and suscep-
tible mares have differences in protein composition of
their endometrial fluid [9]. Susceptible mares have
higher levels of proinflammatory cytokines and lower
levels of anti-inflammatory cytokines after induction of
uterine inflammation [10,11]. However, administration
of an immunomodulator provoked protein alteration,
characterized by higher gene expression levels of the
anti-inflammatory cytokine interleukin (IL)-10 and a
uterine environment similar to that found in resistant
mares [12].
Corticotherapy has been proposed to modulate the
uncoordinated uterine inflammatory response of sus-
ceptible mares; it often increased pregnancy rates when
it is given before AI [13,14] and improved clinical end
oints, e.g., reduced turbidity of endometrial fluid [15].
owever, these studies did not characterize the endo-
etrial immunologic events that occurred in the in-
amed uterus, and how they were altered in response to
orticotherapy.
Proteins are involved in essentially all cellular func-
ions [16]. A key feature in inflammation is excessive
roduction of a group of specific proteins called acute
hase proteins (APP) [17]. Their roles include mediat-
ng the inflammatory process by inhibiting proteases
nd scavenging free radicals [18], among other func-
ions. Identification of these proteins could provide
aluable information regarding the underlying mecha-
isms in susceptible mares. The objective of the current
tudy was to determine the effects of corticotherapy, in
he presence and absence of a uterine infectious pro-
ess, on endometrial fluid proteomics in mares suscep-
ible to persistent postbreeding endometritis.
. Materials and methods
.1. Mares
Eleven mares (4 to 30 yr old) of various breeds,
usceptible to endometritis, cyclic, and clinically
ealthy, were used. Susceptibility was determined ac-
ording to Malschitzky et al. [9]. Mares were artificially
nseminated with 500  106 sperm diluted in skimmed
milk (final volume, 20 mL); those with an intrauterine
fluid accumulation  15 mm in diameter (based on
ultrasonographic examination of the uterus 36 to 48 h
after AI), were classified as susceptible. These mares
were part of an experimental herd and were maintainedin an open field, supplemented with oats and alfalfa
hay, with ad libitum access to water.
2.2. Reproductive management
Mares were given 5 mg prostaglandin F2 im
(PGF2; Lutalyse, Pfizer Saúde Animal, Paulínia, SP,
Brazil), at 14-day intervals and estrus was confirmed by
transrectal palpation and ultrasonographic examination
of the reproductive tract. When estrus was confirmed
(ovarian follicle  35 mm in diameter and marked
uterine edema), mares were subjected to four treat-
ments (done consecutively, at every second estrus pe-
riod). To ensure that all mares were in estrus at sample
collection, they were routinely examined by transrectal
palpation and ultrasonographic examination of the re-
productive tract at 12-h intervals to detect ovulation. If
a mare ovulated during treatments, those data were not
used.
Before starting each treatment, clinical examinations
of the genital tract and endometrial cytology, using a
guarded swab, was performed on all mares to ensure
that there was no pre-existing endometritis. Only mares
without cytologic evidence of endometritis (absence of
polimorphonuclear neutrophils in the slide at magnifi-
cation  400 [19]), were used.
2.3. Control treatment (control)
Mares did not receive any treatment.
2.4. Corticotherapy treatment (GC)
Mares were given 20 mg isoflupredone acetate im
(Predef, Pfizer Saúde Animal) given every 12 h, for
three consecutive days, after the mares were confirmed
in estrus.
2.5. Experimental infection (Infected)
Streptococcus equi subspecies zooepidemicus (S.
zooepidemicus) was isolated from a mare with clinical
signs of endometritis. After isolation, bacteria were
cultured in brain heart infusion (BHI) for 24 h. Glycerol
was added to the bacteria in BHI bouillon, placed in
2.0-mL vials (Eppendorf do Brasil, São Paulo, SP,
Brazil) which were put directly into a 20 °C freezer.
Before infusion, bacteria were thawed in a water bath at
37 °C, cultured in BHI for 24 h (37 °C) and seeded onto
100-mm blood-agar dishes (20 to 30 dishes). Dishes
were incubated at 37 °C for 24 h to allow bacterial
growth. Dishes were washed with PBS and bacterial
colonies were carefully removed. The resulting bacte-
rial suspension was then filtered to remove agar parti-
cles and resuspended in PBS to a final concentration of
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1353C.A. Wolf et al. / Theriogenology 77 (2012) 1351–13591  109 colony-forming unit/mL. The suspension was
placed in 20-mL vials and kept at 5 °C until use. When
estrus was confirmed, an insemination pipette was used
to infuse the suspension into the uterus [20].
2.6. Corticotherapy  experimental infection (GC 
Infected)
Corticotherapy and S. zooepidemicus infusion were
erformed as described above, with bacterial cultures
eing infused 24 h after the first GC treatment.
All mares were submitted to all four treatments and
etween each treatment, they had at least one estrous
ycle. The first estrus was used for the control treat-
ent, the third estrus for the corticotherapy (GC), the
fth estrus for the experimental infection (Infected) and
he seventh estrus for corticotherapy  Infection (GC 
nfected). Before all transvaginal manipulations, the
are’s tail was wrapped and the perineal region
leaned with water, neutral detergent, and degermant
olution (Laboriodine, segmenta; Ribeirão Preto, SP,
razil) and dried with a paper towel.
To ensure that inflammation was absent before start-
ng the next treatment, at the end of the latest sample
ollection, mares were treated by uterine washing and
ntrauterine infusion of 10  106 IU penicillin (No-
apen; Marcolab, São João do Paraíso, MG, Brazil) for
days. Mares were monitored based on the absence of
eutrophils in a uterine swab and the absence of uterine
uid accumulation.
.7. Sample collection
Nondiluted endometrial fluid samples were collected
2 h after the end of each treatment. Control treatment
ares’ were collected 12 h after estrus detection. Com-
ercial vaginal tampons (Mini OB; Johnson & Johnson
ndustrial, Ltda., São José dos Campos, SP, Brazil)
ere antiseptically introduced into the uterus, accord-
ng to the method of Reilas [21], modified by
alschitzky et al. [9]. The tampon was inserted through
he cervix, protected by a palpation glove (double-
love technique). The distal part of a palpation glove
as cut to form a plastic tube and the gloved hand with
he tampon was introduced in the plastic tube, closing
ts end with a finger. The plastic tube was removed at
he moment of the tampon’s introduction in the uterus,
here it remained for 30 min. The tampon was then
emoved, protected by a palpation glove and, immedi-
tely, inserted in a sterile plastic sack and pressed in a
anual device for fluid recovery. The recovered fluid
5 mL) was transferred to conic tubes and immedi-
tely centrifuged (1500  g, for 20 min). The super-atant was transferred to cryovials in 2-mL aliquots,
hich were stored in a freezer at 80 °C, until further
nalyses.
.8. Electrophoresis
Endometrial samples were thawed at room temper-
ture and centrifuged at 1  104  g, for 1 h at 4 °C.
upernatant was recovered, aliquoted and stored at
80 °C. Protein content was determined according to
he method of Lowry et al. [22], using 1 mg/mL bovine
erum albumin (BSA; A7906, Sigma-Aldrich, St.
ouis, MO, USA) as a standard. Samples were sub-
ected to two-dimensional polyacrylamide gel electro-
horesis (2D-PAGE) in duplicate, as described by
’Farrell et al. [23], modified by Rodnight et al. [24].
.8.1. First dimension
For isoelectric focusing (first dimension), nonequi-
ibrium pH gel electrophoresis (NEPHGE) was per-
ormed in 3.5% acrylamide gels. Gels were manufac-
ured in glass (150  2.5 mm in diameter). To make 50
L of gel mixture (600 L per tube), 27.6 g of urea
was diluted in 15 mL of ultra pure water (Milli-Q;
Millisul, Porto Alegre, RS, Brazil) at 60 °C. Then, 5.65
mL of acrylamide (30% stock solution), 0.250 mL of
anpholyte 2 to 4 (Servalyt; Serva Electrophoresis,
Heidelberg, Germany), 0.250 mL of anpholyte pH 5–7
(Ampholine; GE Healthcare Bio-Sciences, Uppsala,
Sweden), 2 mL of anpholyte pH 3–10 (Pharmalyte; GE
Healthcare Bio-Sciences), 1 mL of Igepal (CA-630;
Sigma-Aldrich), 0.083 mL of TEMED (TEMED 100%,
GE Healthcare Bio-Sciences), and ultra pure water (to
reach the desired volume) were added. Immediately
after the addition of 10% ammonium persulfate, the
glass tubes were filled with the gel mixture up to 3.5 cm
from the end by suction, using a 1-mL syringe con-
nected to latex tubing and connected at the other end of
the glass tube. Gels remained in a water bath at 37 °C
for 2 h for polymerization. Then, 100 g of protein per
ube was added to a sample preparation solution (9 M
rea, 12.5 nM lysine, 7 nM SDS, 4% Igepal (Sigma-
ldrich), and 2% 2-mercaptoethanol) and running
marker (cytochrome C, C2037; Sigma-Aldrich). Gel
runs were performed at a maximum of 800 V, 10 mA,
and 0.125 W per tube, until the marker migrated 8 cm
(approximately 2 to 3 h). Glass tubes were identified
and stored at 20 °C, pending the second dimension
electrophoresis.
2.8.2. SDS-PAGE
For second dimension electrophoresis, first dimen-sion gels were removed from glass tubes using a 5-mL
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1354 C.A. Wolf et al. / Theriogenology 77 (2012) 1351–1359syringe connected to latex tubing, connected at the end
of the glass tube. Using slight pressure, gels were ex-
pelled from the glass tubes approximately 30 sec after
removal of the glass tube from the freezer. Gels were
shaken with SDS-equilibrium buffer with 2-mercap-
oethanol for 20 min (room temperature). Second di-
ension gels were manufactured in 20  18-cm glass
lates as described by O’Farrell [25]. The running gel
ixture contained 12% acrylamide, 1% SDS, 0.375 M
ris-HCl (pH 8.8), and 10% ammonium persulfate.
lectrophoresis was performed at a maximum of 125 V
nd 20 mA per plate, until it reached 3 cm from the end
f the plate (approximately 6 to 7 h), verified by a
unning marker (Bromophenol Blue, B8026; Sigma-
ldrich), added to the upper running buffer.
.9. Staining and drying
Gels were stained overnight in a solution of 0.15%
omassie (Comassie Brilliant Blue R-250; Affymetrix/
SB, Cleveland, OH USA), 53% methanol, and 7%
lacial acetic acid. Gels were then destained in a solu-
ion of 53% methanol and 7% glacial acetic acid under
haking, for at least 4 h or until it became transparent
nd equilibrated in a solution of 50% methanol and 1%
lacial acetic acid for, approximately, 2 h. Gels were
tored between cellophane sheets, scanned (Hewlett-
ackard 6100C; Palo Alto, CA, USA) and analyzed
ith specialized software (Optiquant Acquisition and
nalysis, 02.00; Canberra, Australia) to determine rel-
tive protein content of the bands, expressed in pixels.
he software created a histogram of all pixels in the
mage, defining the distribution of the pixels as a func-
ion of the intensity. The histogram then determined the
olor or level of gray used to display each pixel in the
mage. Protein content of the bands was expressed as
elative percentage, considering 100% the total of the
ands (in pixels) within a defined area (constant to
very gel). Each protein band was a percentage of the
otal. A numbering system was applied to assign each
and and a map of the proteins present was prepared.
very band frequency in all gels was assessed and the
resence or absence of the band was determined in
very gel. Frequency was expressed as a percentage of
he gels in which the band was present, as a function of
he total number of gels in each treatment.
.10. Mass spectrometry
Protein identification was determined by mass spec-
rometry. Statistically relevant (with respect to their
elative optic density and frequency) protein bands
ere excised from the gel and digested with trypsin, asescribed [26]. Peptide sequencing was performed in
he Uniprote-MS Laboratory, at the Biotechnology
enter of Universidade Federal do Rio Grande do Sul,
y a nanoscale separation system (UPLC nanoAC-
UITY, Waters, Milford, MA, USA), connected to a
ass spectrometer (Q-TOF Micro, Waters). Sequences
ere compared for correspondence in a databank
http://www.matrixscience.com).
.11. Statistical analysis
A one-way analysis of variance was performed to
ompare, among groups, the relative optical density of
ach protein band. A Tukey post hoc test was used to
ocate differences and P  0.05 was regarded as sig-
ificant. At least two good resolution gels per sample
ere used. The frequency of protein bands was deter-
ined by 2.
3. Results
Intrauterine infusion of S. zooepidemicus provoked
clinical endometritis in all mares, characterized by an
accumulation of intrauterine fluid (15 mm, as deter-
mined by transrectal ultrasonography) before sample
collection. A total of 102 good quality resolution gels
were analyzed, identifying 72 protein bands, with iso-
electric points (pI) from 4.3 to 10.0 and molecular
weight (MW) from 15 to 105 kDa. In 23 protein bands,
differences in relative optic density and frequency were
detected, from which 10 bands were identified (Table
1) by mass spectrometry. The other 13 protein bands
could not be identified; due to insufficient protein con-
tent, mass spectrometry could not be done.
The identified protein bands with significant differ-
ences in their relative optic density are shown (Table
Table 1
Proteins in intrauterine fluid identified by mass spectrometry,
isoelectric point (pI), molecular weight (MW), and the
corresponding band in 2D-PAGE gel.
Band Protein pI MW (kDa)
3, 5, 7, 9 AAT 5.32 45–46.9
23 Hp 5.59 38.4
29 TT 5.36 15.8
53 ApoA-1 5.65 30.0
65 TF 6.83 78.0
77 IgG 6.53 37.5
87 Actin 5.29 41.7
2D-PAGE, two-dimensional polyacrylamide gel electrophoresis;
AAT, 1-antitrypsin; ApoA-1, apolipoprotein A-1; Hp, haptoglobin;
g, immunoglobulin; TF, transferrin; TT, transthyretin.2). Corticotherapy in the presence of infection in-
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1355C.A. Wolf et al. / Theriogenology 77 (2012) 1351–1359creased 1-antitrypsin (AAT), transthyretin (TT), and
ctin, but reduced immunoglobulin (Ig)G, whereas in-
rauterine infection increased haptoglobin (Hp) and
polipoprotein A-1 (ApoA-1) and decreased transferrin
TF).
Identified protein bands, which presented difference
egarding frequency, are shown (Table 3). Infection
educed levels of AAT and TT, whereas corticotherapy
n the presence of infection increased their frequency.
. Discussion
Clinical aspects of endometritis in the mare have
een well characterized, but little is known regarding
he associated local immunologic changes [8]. The cur-
ent study was apparently the first to document both
ncreases and decreases in APP derived from the equine
ndometrium; previous reports measured plasma con-
entrations or analyzed expression of a single APP gene
8,27]. In mares susceptible to endometritis, proteomic
Table 2
Relative optic density of identified protein bands (expressed as a pe
treated with a glucocorticoid (GC), those with an intrauterine infusio
Band Protein Control
3 AAT 3.07a
5 AAT 2.35a
7 AAT 2.40a
9 AAT 2.45a
23 Hp 3.51a
29 TT 2.72a
53 ApoA-1 3.65a
65 TF 15.83a
77 IgG 1.71a
87 Actin 4.31a,b
Values represent a relative percentage of pixels of each band, relative
superscript differ (P  0.05).
AAT, 1-antitrypsin; ApoA-1, apolipoprotein A-1; Hp, haptoglobin;
able 3
requency of identified protein bands in the intrauterine fluid of
ntreated (control) mares, those treated with a glucocorticoid (GC),
hose with an intrauterine infusion of bacteria (Infected), or both.
Band Protein Control GC Infected GCInfected
3 AAT 92.8a 67.7b 40.9b 100a
5 AAT 89.3a 67.7a,b 40.9b 95a
7 AAT 96.5a 83.9a 40.9b 95a
9 AAT 89.3a 77.4a 31.8b 65a,b
29 TT 32.2a 22.6a 0b 55b
Values indicate the percentage of band appearance (band presence) in
every gel relative to the total of gels in each treatment. Within a row,
values without a common superscript differ (P  0.05).tAAT, 1-antitrypsin; TT, transthyretin.hanges were verified in the endometrial fluid after
orticotherapy, induced bacterial infection of the
terus, or both. The relative optic density and frequency
f several APP were altered by uterine infection or
ere induced by GC treatment. Acute inflammation
nd infection induced an increase in systemic APP
ynthesis [28] within a few hours, dramatically altering
protein synthesis within 4 h. Consequently, APP have
been used to monitor systemic responses to inflamma-
tory and/or infectious processes [29]. However, the
understanding of extrahepatic synthesis of APP is lim-
ited.
In this study, corticotherapy applied in mares in the
absence of infection did not alter relative optic density
of any protein, compared with control. However, in the
presence of infection, corticotherapy provoked higher
proteomic alterations, increasing the relative optic den-
sity and the frequency of AAT and TT and the relative
optic density of actin, and decreased the relative optic
density of IgG. Studies have suggested that GC have
both enhancing and suppressive effects on immune and
inflammatory responses [30], although there have been
some discrepancies. For example, GC can either stim-
ulate or depress the expression of genes from several
families, including complement, chemokines, tumor
necrosis factor (TNF), transforming growth factor
(TGF)-, and major histocompatibility complex (MHC).
he acute phase response is a result of these complex
nteractions and GC actions depend, in part, on duration
nd context of cellular exposure [31].
In vitro studies demonstrated that GC stimulated the
xpression of some APP directly (serum amyloid A
SAA], C-reactive protein [CRP] and C3) [32,33]. Al-
e), in the intrauterine fluid of untreated (control) mares, those
cteria (Infected), or both.
GC Infected GC  infected
3.36a 3.05a 4.39b
2.45a 2.35a 4.39b
2.54a 2.43a 4.21b
2.57a 2.83a,b 4.53b
3.83a,b 4.58b 7.84a,b
3.05a 0b 5.14b
3.42a 5.71b 5.43b
16.43a 10.91b 10.78b
1.87a 4.51b 2.18a
3.21a 3.32a 6.69b
total percentage of gel area. Within a row, values without a common
unoglobulin; TF, transferrin; TT, transthyretin.rcentag
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to thehough their action alone is weak, they act strongly in
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1356 C.A. Wolf et al. / Theriogenology 77 (2012) 1351–1359synergy with cytokines [34], which are produced and
released following an inflammatory stimulus, e.g., in-
fection [35]. The increase in TT frequency induced by
corticotherapy in this study could be associated with
protection of inflamed tissue by vitamin A. In that
regard, transthyretin has an important role in the trans-
port of retinol [36] and it is believed that this vitamin is
required for glycoprotein synthesis [37,38]. Because
almost all APP are glycoproteins [39–42], including
AAT [43], perhaps the equine endometrium synthesizes
APP.
In the present study, the enzyme AAT was present in
more than 89% of mares during control treatment, but
after induction of uterine infection, it was detected in
only 40.9% of the mares. Alpha 1-antitrypsin is present
in the equine uterus, with higher concentrations during
estrus than in diestrus [44]. However, corticotherapy in
he presence of infection increased the enzyme fre-
uency (to 100% of mares), and also increased its
elative optic density, when compared with infected
ares and to those where corticotherapy was applied in
he absence of uterine bacterial challenge. Therefore,
e inferred that GC increased AAT in the presence of
n infectious process. The stimulus was attributed to
eutrophil proteases [45], because AAT is the main
inhibitor of these proteases [46]. Neutrophils migrate
from the circulating blood to infected tissues, where
they engulf and inactivate bacteria, by the action of a
complex of substances contained inside their granules,
including proteases (e.g., elastase [47]). The antipro-
tease/neutrophil elastase balance is very important in
the inflammatory processes, because an imbalance fa-
vors uncontrolled proteolytic activity of the elastase
[48]. In humans [49] and horses [48], an AAT defi-
iency has been implicated in development of chronic
bstructive pulmonary disease; excess proteolytic ac-
ion provokes tissue damage. It is also suggested that
xcess neutrophil elastase is responsible for permanent
amage to the endometrium, including periglandular
brosis formation, one of the causes of reduced fertility
n mares with recurrent endometritis episodes [44].
As well as the protective action of the antiprotease,
here is also evidence that AAT has anti-inflammatory
ffects, because treatment with this enzyme protected
ransplant organs, which remain intact [50], and it in-
reases IL-10 [51] and IL-1RA concentrations [49,51],
decrease cellular infiltrate [49,50,52], the expression of
proinflammatory [50,51] and chemotactic mediators
[49,52], and the release of other inflammatory factors,
like nitric oxide and major histocompatibility com-
plex-II [50]. Alpha 1-antitrypsin also inhibits superox- mide production by neutrophils [53] and reduces the
oxicity of bacterial endotoxins [54] in addition to
NF- release [55] in vivo.
The presence of actin can either indicate local dam-
age or higher neutrophil migration [56]. Actin is the
main component of the cellular cytoskeleton, present in
every eukaryote cell [57]. An intact cytoskeleton is
essential for cell motility and activation [58]. Actin
remodeling is crucial for neutrophil movement, because
inhibition of actin polymerization completely blocks
chemotaxis. Due to the rapid reorganization of actin,
neutrophils are able to orient their migration and exhibit
chemotactic movement, enabling them to accumulate at
sites of injury. There is recent evidence that actin rear-
rangement can be crucial in regulating the inflamma-
tory response, by decreasing nitric oxide production,
prostaglandin E2 release and TNF- secretion [59].
herefore, in the present study, increases in actin, AAT
nd TT and decreased IgG after corticotherapy, may
ave protected the endometrium from damage caused
y inflammatory products, demonstrating an immuno-
odulatory action of GC.
In this study, intrauterine challenge with S. zooepi-
emicus provoked total disappearance of TT, compared
ith its presence in the control treatment. Otherwise TF
as constantly present (constant frequency), but its
elative optic density decreased after infection in compar-
son with the control. Transthyretin and TF are usually
onsidered negative APP [36,60], which are normally
resent in healthy animals, but their concentrations de-
rease during inflammation [60]. The decrease of negative
PP occurs due to the use of their amino acids by the liver
or the production of positive APP, which concentrations
ncrease as part of the inflammatory process [42].
In this study, the relative optic density of Hp in-
reased in response to the induced inflammation. Hap-
oglobin is a positive APP; therefore, its concentration
ncreases within the inflammatory process [61] suggest-
ng that this protein participates directly in tissue pro-
ection. The main and best known function of Hp is to
revent the loss of iron, by formation of a stable com-
lex with free hemoglobin (Hb) in circulating blood
62]. Haptoglobin binds to hemoglobin released by
amaged erythrocytes [63] and helps to diminish the
amaging effects of free iron and to prevent the avail-
bility of this metal for bacterial growth [61]. There-
ore, bacteriostatic and anti-inflammatory actions can
e attributed to Hp [40].
In the present study, SAA, a positive APP that is a
apidly responding and very sensitive marker of inflam-
ation in the horse [64], was not detected, probably
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1357C.A. Wolf et al. / Theriogenology 77 (2012) 1351–1359due to its small size, 14 kDa [65], because the electro-
horesis technique used in this study was only able to
eparate proteins  15 kDa.
In the present study, an increase in the relative
ptic density of ApoA-1 occurred after infection.
his protein is normally considered a negative APP
66,67]. Abundant levels of ApoA-1 have been dem-
nstrated in cases of human arthritis [68] as well as an
nhibitory capacity of this APP on activation of mono-
ytes and production of proinflammatory cytokines
L-1 and TNF- by T cells [69]. These data were
onsistent with anti-inflammatory effects of ApoA-1,
ecause concurrent treatment with this protein reduced
igns of arthritis and also IL-1 [70].
An increase in the relative optic density of IgG after
bacterial infection occurred in this study, suggesting
that antibody-mediated uterine defense remained func-
tional in susceptible mares. Although this category of
mares have delayed uterine clearance attributed to sev-
eral factors, including an alteration of humoral and
cellular defense mechanisms [71], higher concentra-
tions of IgG and C3 were reported in the endometrial
fluid of susceptible mares [72], with more cells con-
taining IgG, IgA, and IgM in the endometrial fluid from
mares with varying degrees of endometritis, in compar-
ison with genitally normal mares [73]. Therefore, we
inferred that a nonhumoral response must be involved
in the resolution of endometritis [71].
In conclusion, corticotherapy altered the endometrial
fluid proteomics of mares susceptible to endometritis,
with the most pronounced effects occurring when corti-
cotherapy was applied in the presence of an infected
uterus. Glucocorticoids are involved in modulation of the
inflammatory process possessing anti-inflammatory ef-
fects (manifested as the decrease of IgG) and also stimu-
latory effects (induction of an increase of important pro-
teins, such as AAT, TT, and actin, enhancing the defense
mechanism, and protection of inflamed tissue). Short-term
corticotherapy, such as that used in this study, could be
beneficial for the treatment of uterine infectious processes.
Additionally, uterine lumen infection altered proteomics
of the endometrial fluid, characterized by a variation of
important APP, including increased Hp, ApoA-1, and
IgG, and decreased AAT, TT, and TF.
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